Interleukin-1beta up-regulates RGS4 through the canonical IKK2/IkappaBalpha/NF-kappaB pathway in rabbit colonic

Wenhui Hu1, Fang Li, Sunila Mahavadi

  • 1Departments of Physiology and Medicine, Medical College of Virginia Campus, Virginia Commonwealth University, Richmond, VA 23298, USA. whu@vcu.edu

The Biochemical Journal
|February 12, 2008
PubMed

Insights

Interleukin-1beta increases Regulator of G-protein Signalling 4 expression via the NF-kappaB pathway, inhibiting intestinal smooth muscle contraction. This reveals a new mechanism for controlling muscle response.

Area of Science:

  • Gastroenterology
  • Molecular Biology
  • Cell Signalling

Background:

  • Regulator of G-protein signalling 4 (RGS4) attenuates G(q)-coupled receptor-mediated intestinal smooth muscle contraction.
  • Interleukin-1beta (IL-1beta) inhibits acetylcholine-stimulated contraction by upregulating RGS4.
  • Nuclear Factor kappaB (NF-kappaB) signalling is the primary pathway activated by IL-1beta.

Purpose of the Study:

  • To investigate if RGS4 is a target gene of the IL-1beta/NF-kappaB signalling pathway.
  • To elucidate the mechanism by which IL-1beta regulates RGS4 expression and affects smooth muscle contraction.

Main Methods:

  • Cultured rabbit colonic muscle cells were treated with IL-1beta.
  • RGS4 mRNA expression was measured.
  • NF-kappaB pathway activation was assessed using reporter assays, DNA binding activity, protein translocation, and phosphorylation.
  • Specific inhibitors and small interfering RNA (siRNA) were used to block pathway components.
  • Phospholipase C-beta (PLC-beta) activation was measured.

Main Results:

  • IL-1beta rapidly increased RGS4 mRNA expression in a transcription-dependent manner.
  • The canonical IKK2/IkappaBalpha pathway mediated IL-1beta-induced NF-kappaB activation.
  • IL-1beta-induced RGS4 up-regulation was dependent on IKK2, IkappaBalpha, and NF-kappaB.
  • Inhibition of IKK2 or NF-kappaB blocked IL-1beta's effect on acetylcholine-stimulated PLC-beta activation.

Conclusions:

  • The canonical IKK2/IkappaBalpha/NF-kappaB pathway mediates IL-1beta-induced RGS4 expression in colonic smooth muscle.
  • This pathway contributes to IL-1beta's inhibitory effect on acetylcholine-stimulated contraction by modulating PLC-beta activation.

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
Renewal of Intestinal Stem Cells01:23

Renewal of Intestinal Stem Cells

The intestinal epithelial lining rapidly renews every 4 to 5 days. The renewal is facilitated by intestinal stem cells (ISCs) located at the base of the crypt– a gland located at the bottom of each villus. ISCs divide asymmetrically to form new stem cells and progenitor daughter cells. The daughter cells are called transit-amplifying (TA) cells which move upwards along the crypt and either differentiate into absorptive cells– the enterocytes or secretory cells– including the goblet,...